Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesCMV-Specific TCR-Transgenic T Cells for Immunotherapy
Journal of Immunology, 11/09/09
Schub A et al. – The CMV–TCR–transgenic T cells displayed a broad spectrum of important effector functions (secretion of IFN– and IL–2, cytotoxicity, proliferation) in response to endogenously processed pp65 and could be enriched and expanded by strictly Ag–specific stimulation. Expansion of engineered T cells was accompanied by an increase in specific effector functions, indicating that the transferred specificity is stable and fully functional. Hence, the authors expect these CMV–TCR–transgenic T cells to be effective in controlling acute CMV disease and establishing an antiviral memory.
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatitis B vaccinations among Koreans: Results from 2005 Korea National Cancer Screening Survey
BMC Infectious Diseases, 11/25/09
Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection
Mucosal Immunology, 11/24/09
Coverage and Predictors of Adherence to Influenza Vaccination among Spanish Children and Adults with Asthma
Infection, 11/23/09
Article Search
Sponsor